Chronic β3 adrenergic agonist treatment improves brain microvascular endothelial function and cognition in aged mice
Natarajan, D.; Ekambaram, S.; Tarantini, S.; Yelahanka Nagaraja, R.; Yabluchanskiy, A.; Hendrik, A.; Awasthi, V.; Subramanian, M.; Csiszar, A.; Balasubramanian, P.
Show abstract
Microvascular endothelial dysfunction, characterized by impaired neurovascular coupling, reduced glucose uptake, blood-brain barrier disruption, and microvascular rarefaction, plays a critical role in the pathogenesis of age-related vascular cognitive impairment (VCI). Emerging evidence points to non-cell autonomous mechanisms mediated by adverse circulating milieu (an increased ratio of pro-geronic to anti-geronic circulating factors) in the pathogenesis of endothelial dysfunction leading to impaired cerebral blood flow and cognitive decline in the aging population. In particular, age-related adipose dysfunction contributes, at least in part, to an unfavorable systemic milieu characterized by chronic hyperglycemia, hyperinsulinemia, dyslipidemia, and altered adipokine profile, which together contribute to microvascular endothelial dysfunction. Hence, in the present study, we aimed to test whether thermogenic stimulation, an intervention known to improve adipose and systemic metabolism by increasing cellular energy expenditure, could mitigate brain endothelial dysfunction and improve cognition in the aging population. Eighteen-month-old old C57BL/6J mice were treated with saline or CL ({beta}3-adrenergic agonist) for 6 weeks followed by functional analysis to assess endothelial function and cognition. CL treatment improved neurovascular coupling responses and rescued brain glucose uptake in aged animals. In addition, CL treatment also attenuated blood-brain barrier leakage and associated neuroinflammation in the cortex of aged animals. More importantly, these beneficial changes in microvascular function translated to improved cognitive performance in radial arm water maze and Y-maze tests. Our results suggest that {beta}3-adrenergic agonist treatment improves multiple aspects of brain microvascular endothelial function and can be potentially repurposed for treating age-associated cognitive decline.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Canagliflozin reprograms the aging hippocampus in genetically diverse UM-HET3 mice and attenuates Alzheimer's-like pathology 95%
- Neuroprotective effects of Canagliflozin: lessons from aged genetically diverse UM-HET3 mice. 94%
- A single short reprogramming early in life improves fitness and increase lifespan in old age 94%
Similar papers in this journal
- Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer's disease 95%
- Increasing NPYergic transmission in the hippocampus rescues aging-related deficits of long-term potentiation in the mouse dentate gyrus 94%
- Plcg2M28L interacts with high fat-high sugar diet to accelerate Alzheimers disease-relevant phenotypes in mice 94%
Similar papers in this journal
- Metformin improves cognition of aged mice by promoting cerebral angiogenesis and neurogenesis 96%
- Hippocampal Transcriptome Profiling Reveals Common Disease Pathways in Chronic Hypoperfusion and Ageing 95%
- Hedgehog dysregulation contributes to tissue-specific inflammaging of resident macrophages 95%
Similar papers in this journal
- Late-life restoration of mitochondrial function reverses cardiac dysfunction in old mice 94%
- Cerebellar Purkinje cell stripe patterns reveal a differential vulnerability and resistance to cell loss during normal aging in mice 94%
- Small molecule cognitive enhancer reverses age-related memory decline in mice. 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.